Context Therapeutics Company
Context Therapeutics is a clinical-stage biopharmaceutical company.
Technology:
Immunotherapy
Industry:
Longevity
Headquarters:
Philadelphia, Pennsylvania, United States
Founded Date:
01-01-2015
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
$31,250,000
Last Funding Date:
2021-12-06
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership